Goldman Sachs US Sanctions Have Limited Impact on Russias Crude Exports Oil Prices Dip
Indian Corporate Balance Sheets Show Maturity as Interest Coverage Ratios Strengthen
SP 500 Edges Higher as Healthcare and Tech Rally Outweigh Communication Services Dip
Egypt QatarEnergy and ExxonMobil Partner to Ship Cypriot Gas to Europe via Egyptian LNG Facilities
US Pauses Arms Sales to Taiwan Amid Iran Conflict Acting Navy Chief Indicates
Trump Skips Sons Wedding as Family Health Revelation Emerges
Nicolet Bankshares Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Amid Challenging Environment
Moving iMage Technologies Inc MITQ Q1 2026 Earnings Net Loss Reported as Stock Edges Higher
FLR Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher
BTQ Technologies Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 1183
GKOS Q1 2026 Earnings EPS Beat Masks Broader Concerns as Stock Drops 135
PEW Q1 2026 Earnings Loss Narrows Sharply Stock Slips on Mixed Sentiment
BlackRock Capital Allocation Term Trust BCAT Modestly Gains as Price Hovers Near MidRange
Assurant Inc AIZ Navigates Slight Decline While Holding Key Support Levels
MIND CTI Ltd MNDO Edges Higher Amid Consolidation Key Levels to Watch
Eaton Vance Global Diversified Equity Income Fund EXG Modest Pullback as Shares Test Support Zone
Republic Airways Slides 218 Approaches Key Support as Regional Airline Sector Weakens
Cambium Networks CMBM Q3 2024 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Demand Uncertainty
PRIM Q1 2026 Earnings EPS Misses Estimate by 315 Stock Still Climbs 69
Valaris Limited VAL Q1 2026 Earnings EPS Misses Wide Stock Holds Steady
BODI Q1 2026 Earnings EPS Surges to 030 Smashing Estimates by 2634
Community Healthcare Trust Incorporated CHCT Q1 2026 Earnings Massive Earnings Surprise as Profitability Rebounds Sharply
KR Q1 2026 Earnings EPS Beat Drives Modest Stock Gain
Union Bank Board Approves Up to 8000 Crore Capital Raise via Equity and Debt
KGS Q1 2026 Earnings EPS Surprise Drives Optimism Despite Slight Stock Decline
Inhibikase Therapeutics IKT Recovers 35 as Buyers Defend Key Support Level